Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests

American Journal of Tropical Medicine and Hygiene

Volumn 92, Issue 4, 2015, Pages 818-824

  Bancone, Germana ^a   Chu, Cindy S ^a   Chowwiwat, Nongnud ^a   Somsakchaicharoen, Raweewan ^a   Wilaisrisak, Pornpimon ^a   Charunwatthana, Prakaykaew ^a   Bansil, Pooja ^b   McGray, Sarah ^b   Domingo, Gonzalo J ^b   Nosten, François H ^a,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b PATH   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN; 8-AMINOQUINOLINE; AMINOQUINOLINE DERIVATIVE; ANTIMALARIAL AGENT; PRIMAQUINE;

ARTICLE; CAPILLARY BLOOD; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME ACTIVITY; ERYTHROCYTE COUNT; HEMOGLOBIN DETERMINATION; HUMAN; MALARIA; MALARIA RAPID TEST; NORMAL HUMAN; PHENOTYPE; POINT OF CARE TESTING; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETER; SPECTROPHOTOMETRY; VENOUS BLOOD; BLOOD; CAPILLARY; COMPARATIVE STUDY; ENZYME ASSAY; ENZYMOLOGY; ERYTHROCYTE; EVALUATION STUDY; FEMALE; GENETICS; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; MALARIA, VIVAX; MALE; POINT OF CARE SYSTEM; PROCEDURES; VEIN;

AMINOQUINOLINES; ANTIMALARIALS; CAPILLARIES; CLINICAL ENZYME TESTS; ERYTHROCYTES; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; MALARIA, VIVAX; MALE; POINT-OF-CARE SYSTEMS; PRIMAQUINE; SENSITIVITY AND SPECIFICITY; VEINS;

EID: 84926323959     PISSN: 00029637     EISSN: 14761645     Source Type: Journal    
DOI: 10.4269/ajtmh.14-0696     Document Type: Article

References (22)

1. Howes RE, Dewi M, Piel FB, Monteiro WM, Battle KE, Messina JP, Sakuntabhai A, Satyagraha AW, Williams TN, Baird JK, Hay SI, 2013. Spatial distribution of G6PD deficiency variants across malaria-endemic regions. Malar J 12: 418.
2. Nuchprayoon I, Louicharoen C, Charoenvej W, 2008. Glucose-6-phosphate dehydrogenase mutations in Mon and Burmese of southern Myanmar. J Hum Genet 53: 48-54.
3. Phompradit P, Kuesap J, Chaijaroenkul W, Rueangweerayut R, Hongkaew Y, Yamnuan R, Na-Bangchang K, 2011. Prevalence and distribution of glucose-6-phosphate dehydrogenase (G6PD) variants in Thai and Burmese populations in malaria endemic areas of Thailand. Malar J 10: 368.
4. Beutler E, Mitchell M, 1968. Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. Blood 32: 816-818.
5. Kuwahata M, Wijesinghe R, Ho MF, Pelecanos A, Bobogare A, Landry L, Bugora H, Vallely A, McCarthy J, 2010. Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots. Malar J 9: 223.
6. De Niz M, Eziefula AC, Othieno L, Mbabazi E, Nabukeera D, Ssemmondo E, Gonahasa S, Tumwebaze P, Diliberto D, Maiteki-Sebuguzi C, Staedke SG, Drakeley C, 2013. Tools for mass screening of G6PD deficiency: validation of the WST8/1-methoxy-PMS enzymatic assay in Uganda. Malar J 12: 210.
7. Tinley KE, Loughlin AM, Jepson A, Barnett ED, 2010. Evaluation of a rapid qualitative enzyme chromatographic test for glucose- 6-phosphate dehydrogenase deficiency. Am J Trop Med Hyg 82: 210-214.
8. Kim S, Nguon C, Guillard B, Duong S, Chy S, Sum S, Nhem S, Bouchier C, Tichit M, Christophel E, Taylor WR, Baird JK, Menard D, 2011. Performance of the CareStart G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS ONE 6: e28357.
9. Daae LN, Halvorsen S, Mathisen PM, Mironska K, 1988. A comparison between haematological parameters in 'capillary' and venous blood from healthy adults. Scand J Clin Lab Invest 48: 723-726.
10. Daae LN, Hallerud M, Halvorsen S, 1991. A comparison between haematological parameters in 'capillary' and venous blood samples from hospitalized children aged 3 months to 14 years. Scand J Clin Lab Invest 51: 651-654.
11. Schalk E, Heim MU, Koenigsmann M, Jentsch-Ullrich K, 2007. Use of capillary blood count parameters in adults. Vox Sang 93: 348-353.
12. Beutler E, Blume KG, Kaplan JC, Lohr GW, Ramot B, Valentine WN, 1977. International Committee for Standardization in Haematology: recommended methods for red-cell enzyme analysis. Br J Haematol 35: 331-340.
13. Missiou-Tsagaraki S, 1991. Screening for glucose-6-phosphate dehydrogenase deficiency as a preventive measure: prevalence among 1,286,000 Greek newborn infants. J Pediatr 119: 293-299.
14. Reclos GJ,Hatzidakis CJ, Schulpis KH, 2000. Glucose-6-phosphate dehydrogenase deficiency neonatal screening: preliminary evidence that a high percentage of partially deficient female neonates are missed during routine screening. J Med Screen 7: 46-51.
15. Nantakomol D, Paul R, Palasuwan A, Day NP, White NJ, Imwong M, 2013. Evaluation of the phenotypic test and genetic analysis in the detection of glucose-6-phosphate dehydrogenase deficiency. Malar J 12: 289.
16. Ainoon O, Alawiyah A, Yu YH, Cheong SK, Hamidah NH, Boo NY, Zaleha M, 2003. Semiquantitative screening test for G6PD deficiency detects severe deficiency but misses a substantial proportion of partially-deficient females. Southeast Asian J Trop Med Public Health 34: 405-414.
17. Nadarajan V, Shanmugam H, Sthaneshwar P, Jayaranee S, Sultan KS, Ang C, Arumugam S, 2011. Modification to reporting of qualitative fluorescent spot test results improves detection of glucose-6-phosphate dehydrogenase (G6PD)-deficient heterozygote female newborns. Int J Lab Hematol 33: 463-470.
18. LaRue N, Kahn M, Murray M, Leader BT, Bansil P, McGray S, Kalnoky M, Zhang H, Huang H, Jiang H, Domingo GJ, 2014. Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency. Am J Trop Med Hyg 91: 854-861.
19. Eziefula AC, Bousema T, Yeung S, Kamya M, Owaraganise A, Gabagaya G, Bradley J, Grignard L, Lanke KH, Wanzira H, Mpimbaza A, Nsobya S, White NJ, Webb EL, Staedke SG, Drakeley C, 2014. Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, doubleblind, dose-ranging trial. Lancet Infect Dis 14: 130-139.
20. Kosaryan M, Mahdavi MR, Jalali H, Roshan P, 2014. Why does the Iranian national program of screening newborns for G6PD enzyme deficiency miss a large number of affected infants? Pediatr Hematol Oncol 31: 95-100.
21. Turner C, Carrara V, Aye Mya Thein N, Chit Mo Win N, Turner P, Bancone G, White NJ, McGready R, Nosten F, 2013. Neonatal intensive care in a Karen refugee camp: a 4 year descriptive study. PLoS ONE 8: e72721.
22. von Fricken ME,Weppelmann TA, Eaton WT, Masse R, Beau de Rochars MV, Okech BA, 2014. Performance of the CareStart Glucose-6-Phosphate Dehydrogenase (G6PD) rapid diagnostic test in Gressier, Haiti. Am J Trop Med Hyg 91: 77-80.